News

NeuClone moves to the Australian Technology Park

July, 2008. NeuClone joins ATP Innovations, a vibrant, world-class technology commercialization hub located within the Australian Technology Park (ATP), on the fringe of the Sydney CBD. The new facilities will allow us to  provide quality products and services in cell line development under strictly regulated conditions.  The facility will be compliant with the Principles of GLP of the OECD under the Australian GLP compliance monitoring program recognized by NATA. Quality Systems are designed to meet the requirements of the cGMP Quality System Regulation, the ISO 13485:2003 international standard. 

NeuClone is proud to have been selected to participate in a Trade Mission to the United Arab Emirates 28-31 January 2008

January 28-31, 2008. The mission to Dubai was sponsored by the NSW Department of State and Regional Development and coincided with the Arab Health 2008 healthcare exhibition and congress in Dubai, UAE. The Middle East is one of the world's fastest growing and most lucrative healthcare markets, worth over US$81 billion.

NeuClone receives funding under the Commercial Ready Plus scheme

Through AusIndustry, the Commercial Ready Plus supports research and development, proof-of-concept and early-stage commercialisation activities. Commercial Ready Plus offers innovation grants of up to $250,000 for projects of up to 18 months duration.

NeuClone receives COMET grant funding

COMET (Commercialising Emerging Technologies) is an Australian government initiative offered through AusIndustry COMET is a competitive, merit based program that supports early-growth stage and spin off companies to successfully commercialise their innovations.